Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;46(3):337-347.
doi: 10.1016/j.jgr.2022.02.006. Epub 2022 Feb 25.

Can Panax ginseng help control cytokine storm in COVID-19?

Affiliations
Review

Can Panax ginseng help control cytokine storm in COVID-19?

Jong Hee Choi et al. J Ginseng Res. 2022 May.

Abstract

Coronavirus disease 2019 (COVID-19) is currently a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 are directly associated with hyper-activation of innate immune response that excessively produce pro-inflammatory cytokines and induce cytokine storm, leading to multi-organ-failure and significant morbidity/mortality. Currently, several antiviral drugs such as Paxlovid (nirmatrelvir and ritonavir) and molnupiravir are authorized to treat mild to moderate COVID-19, however, there are still no drugs that can specifically fight against challenges of SARS-CoV-2 variants. Panax ginseng, a medicinal plant widely used for treating various conditions, might be appropriate for this need due to its anti-inflammatory/cytokine/viral activities, fewer side effects, and cost efficiency. To review Panax ginseng and its pharmacologically active-ingredients as potential phytopharmaceuticals for treating cytokine storm of COVID-19, articles that reporting its positive effects on the cytokine production were searched from academic databases. Experimental/clinical evidences for the effectiveness of Panax ginseng and its active-ingredients in preventing or mitigating cytokine storm, especially for the cascade of cytokine storm, suggest that they might be beneficial as an adjunct treatment for cytokine storm of COVID-19. This review may provide a new approach to discover specific medications using Panax ginseng to control cytokine storm of COVID-19.

Keywords: Coronavirus disease 2019; Cytokine storm; Panax ginseng; SARS-CoV-2; Therapeutic strategies.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest associated with this publication. There has been no significant financial support for this work that could have influenced its outcome.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
The immunopathological mechanisms of cytokine storm in COVID-19. SARS-CoV-2 infects the respiratory epithelial cells or induces immune response, resulting in secretion of inflammatory cytokines and damage of cells and tissues. The cytokines stimulate innate immune response as well as adaptive immune response to induce the excessive production of circulating cytokines. The excessive cytokines can destroy epithelial cells or produces hemophagocytic lymphohistiocytosis, macrophage activation/acute respiratory distress syndrome and intravascular coagulation. This events together produce to acute respiratory distress syndrome, multiple organ dysfunction syndromes (lung, liver, heart, kidney, brain, etc.), or death.

References

    1. Pollard C.A., Morran M.P., Nestor-Kalinoski A.L. The COVID-19 pandemic: a global health crisis. Physiol Genom. 2020;52:549–557. - PMC - PubMed
    1. Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130–137. - PMC - PubMed
    1. Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. - PMC - PubMed
    1. Yang L., Liu S., Liu J., Zhang Z., Wan X., Huang B., et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduc Targe Ther. 2020;5:1–8. - PMC - PubMed
    1. Costela-Ruiz V.J., Illescas-Montes R., Puerta-Puerta J.M., Ruiz C., Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. - PMC - PubMed

LinkOut - more resources